Newer drugs used to enhance sporting performance

---

• 1.
• Laura R, White S, editors. Drug controversy in sport. Sydney: Allen and Unwin, 1991: 1-4.
• 2.
• Corrigan AB. Dehydroepiandrosterone and sport. Med J Aust 1999; 171: 206-208.
• 3.
• Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341: 1013-1020.
• 4.
• Wallace MB, Lim LA, Cutler A, Bucci L. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Exercise Sports 1999; 31: 1788-1792.
• 5.
• Yesalis CE. Medical, legal, and social implications of androstenedione use. JAMA 1999; 281: 2043-2044.
• 6.
• King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men. JAMA 1999; 281: 2020-2028.
• 7.
• Leder BZ, Longcope C, Catlin DH, et al. Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 2000; 283: 779-782.
• 8.
• Bowers LD. Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio. Clin Chem 1999; 45: 295-297.
• 9.
• Kicman AT, Coutts SB, Walker CJ, Cowan DA. Proposed confirmatory procedure for detecting 5 alpha-dihydrotestosterone doping in male athletes. Clin Chem 1995; 41: 1617-1627.
• 10.
• Muscling in on clenbuterol [editorial]. Lancet 1992; 340: 403.
• 11.
• Kamburoff PL, Prime FJ, Schmidt OP. The bronchodilator effects of NAB 365. Br J Clin Pharm 1977; 4: 67-71.
• 12.
• Harahan JP, editor. Beta-agonists and their effects on animal growth and carcass quality. London: Elsevier Applied Science, 1987.
• 13.
• Prather ID, Brown DE, North P, Wilson JR. Clenbuterol: a substitute for anabolic steroids? Med Sci Sports Exercise 1995; 27: 1118-1121.
• 14.
• American College of Sports Medicine. The use of blood doping as an ergogenic aid. Med Sci Sports Exercise 1996; 28: 1-8.
• 15.
• Peddling drugs to the pedal pushers [editorial]. Lancet 1998; 352: 415.
• 16.
• Ekblom B. Blood doping and erythropoietin, the effects of variation in haemoglobin concentration and other related factors on physical performance. Am J Sports Med 1996; 24 (6 Suppl): S40-42.
• 17.
• Leith W. EPO and cycling. Athletics Magazine (Willowdale, Ontario, Canada) June 1992: 24-26.
• 18.
• Choi D, Kim M, Park J. Erythropoietin: physico- and biochemical analysis. J Chromatog 1996; 687: 189-199.
• 19.
• Saris WHM, Sneden JMG, Brouns F. What is a normal red-blood cell mass for professional cyclists? [letter]. Lancet 1998; 352: 1758.
• 20.
• Gareau R, Audran M, Baynes RD, et al. Erythropoietin abuse in athletes. Nature 1996; 380: 113.
• 21.
• Willey WJ. Insulin as an anabolic aid? A danger for strength athletes. Physician Sports Med 1997; 25: 103-104.
• 22.
• Dawson RT, Harrison MW. Use of insulin as an anabolic agent. Br J Sports Med 1997; 31: 259.
• 23.
• Council on Scientific Affairs. Drug abuse in athletes. Anabolic steroids and human growth hormone. JAMA 1988; 259: 1703-1705.
• 24.
• Yarasheski KE, Zachwieja JJ, Angleopoulos TJ, Bier DM. Short-term growth hormone does not increase muscle protein synthesis in experienced weight lifters. J Appl Physiol 1993; 74: 3073- 3076.
• 25.
• Taaffe DR, Pruitt L, Reim J, et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994; 79: 1361-1366.
• 26.
• Crist DM, Peake GT, Egan PA, Waters DA. Body composition response to exogenous GH during training in highly conditioned adults. J Appl Physiol 1988; 65: 579-584.
• 27.
• Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. Detection of doping with growth hormone. Lancet 1999; 353: 895.
• 28.
• Bach LA. The insulin-like growth factor system: Basic and clinical aspects. Aust N Z J Med 1999; 29: 355-361.
• 29.
• Ascoli M, Segaloff DL. Adenohypophyseal hormones and their hypothalamic releasing factors. In: Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 1363-1382.
• 30.
• Sapir DG, Mackenzie W, Moyer ED, et al. Effects of alpha-ketoisocaproate and of leucine on nitrogen metabolism in postoperative patients. Lancet 1983; 1: 1010-1014.
• 31.
• -hydroxy--methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol 1996; 81: 2095-2104.
• 32.
• Vukovich MD, Adams GD. HMB may improve Vo_2peak [abstract]. Med Sci Sports Exerc 1997; 29: S252.